International Psychogeriatric Association- IPA

02/12/2026

🔝The success of the International Psychogeriatric Association (IPA) International Congress rests upon the vision and dedication of our leadership committees. As we prepare for our 2026 gathering in Leiden, we are proud to introduce the distinguished experts who are curating an unparalleled scientific and professional experience.🇳🇱

These committees work in synergy to ensure that every aspect of the Congress—from groundbreaking research sessions to local cultural integration—meets the highest international standards.

Our Governing Committees:

🔵The Steering Committee: Providing strategic oversight and organizational direction.

🔵The Scientific Committee: Ensuring the highest caliber of peer-reviewed research and academic programming.

🔵The Local Organizing Committee: Integrating the rich academic heritage of Leiden into our global summit.

📣We invite you to learn more about the esteemed colleagues leading these efforts and explore the full organizational structure of the 2026 Congress.

Meet the Committees 🔗https://f.mtr.cool/hnwlvnnyuf

02/11/2026

🔵The evolution of geriatric psychiatry requires a constant re-evaluation of established diagnostic frameworks. At the IPA 2025 Congress, Dr. Katsuyuki Ukai presented a compelling critique of the current concept of epilepsy, proposing the introduction of a new clinical category: Non-Paroxysmal Epilepsy-Related Disorder (NPED).

🔵Dr. Ukai’s research highlights two specific conditions—Epileptic Cognitive Impairment resembling Alzheimer's disease (ECI-A) and Transient Epileptic Amnesic Complex Syndrome (TEACS)—where patients exhibit chronic cognitive dysfunction driven by excessive neuronal discharges, even in the complete absence of clinical seizures.

🔵The successful treatment of these cognitive symptoms with anti-seizure medications suggests a critical need to broaden our diagnostic criteria. By recognizing "epileptic pathology" beyond paroxysmal events, clinicians can better address cognitive decline that may currently be misdiagnosed or undertreated.

📣Access the full abstract and the complete 2025 scientific program through the IPA website. 2025 IPA Abstract Book | Kanazawa, Japan 🔗https://f.mtr.cool/oczkgwoyjh

02/10/2026

📣LATE BREAKING ABSTRACT SUBMISSION SITE NOW OPEN!
📅Late Breaking Abstract Deadline March 10, 2026
*Free/Oral and Poster submissions ONLY

IPA Abstract submission site is now open for late breaking free/oral and poster presentations for the 2026 International Congress in Leiden, The Netherlands.

For more details and/or to submit🔗https://f.mtr.cool/ueryjcsveq

02/10/2026

It's already February 10th! For the Virtual Rounds in French

💎 Vidéoconférences gériatriques internationales sur la santé mentale (I-GeMH)

QUAND
Mardi 10 février 2026
De 11 h à 12 h (heure normale de l’Est – HNE)

SUJET
Le dépistage précoce : les bons outils, les bonnes conclusions!

ORATEUR
Robert Laforce, MD PhD

👉 S'INSCRIRE
https://us06web.zoom.us/meeting/register/a25t72uxTrKtcb-A5SteKQ

NOTEZ: Cette activité d’apprentissage est réservée aux clinicien(ne)s, aux étudiant(e)s et aux chercheur(e)s dans le domaine de la santé

Canadian Academy of Geriatric Psychiatry

02/09/2026

In recognition of International Epilepsy Day, the IPA revisits critical research presented at our 2024 Congress. We highlight a significant case study by Andrea C. Casas regarding the pharmacological nuances of treating epilepsy in older populations.

🔵The study, "Possible Lamotrigine-Induced Mania in a Patient with Epilepsy and Perictal Psychotic Symptoms," examines a 59-year-old male who developed manic symptoms after long-term treatment with Lamotrigine—a drug typically utilized for its mood-stabilizing properties. This case underscores a rare but critical adverse effect, as the patient’s symptoms only improved upon switching medications.

🔵The Privilege of Clinical Vigilance: While Lamotrigine-induced mania is more commonly documented in mood disorder populations, this report reminds us that geriatric patients with epilepsy require meticulous monitoring. Understanding these neurobiological mechanisms is essential for optimizing safety and quality of life.

Explore more scientific abstracts in our 2024 Book of Abstracts on the IPA website. 🔗 https://f.mtr.cool/ebdanoxcif

02/08/2026

🇳🇱The IPA 2026 International Congress in Leiden, Netherlands, is more than a conference—it is a global summit where the future of geriatric mental health is defined. As the world’s aging population grows, our collective mission to provide innovative, multidisciplinary care has never been more vital.

Why Attend? According to our vision for 2026, the Congress serves as the ultimate platform for:

Scientific Exchange: Presenting original research that challenges current paradigms in dementia, depression, and late-life mental health.

Multidisciplinary Networking: Connecting psychiatrists, neurologists, nurses, social workers, and policymakers from over 50 countries.

Clinical Excellence: Translating high-level theory into practical, accessible care models for diverse populations.

The Privilege of Presence: Join us in the "City of Science" to contribute your voice to the global dialogue. Whether you are an early-career researcher or a seasoned clinician, the IPA Congress is your academic home.

Explore the Congress Vision 🔗https://f.mtr.cool/jbiuiobeyq

02/05/2026

In observance of World Cancer Day, the IPA highlights the critical need for accessible, culturally sensitive palliative care for older adults. We are proud to feature a groundbreaking study by Guangwei Ji, Peiyuan Zhang, and Fei Sun: "Exploring an Innovative Palliative Care Model in Rural China."

🩺As cancer remains a significant challenge for the aging population, innovative models—like the "Sanming Model" discussed in this research—demonstrate how integrated healthcare systems can improve the quality of life for patients in underserved areas. This article explores the synergy between government policy, hospital management, and compassionate end-of-life care.

🩺The Privilege of Global Research: Understanding diverse models of care allows our global community to adapt and implement best practices in various socio-economic contexts. At the IPA, we advocate for palliative care that respects the dignity of older adults, regardless of their geography.

Read the Full Article 🔗Link: https://f.mtr.cool/ptqnqsrcis

02/04/2026

At the International Psychogeriatric Association (IPA), we believe that global challenges in older adult mental health require a unified global response. Our mission is amplified through active collaboration with a prestigious network of national and international partner organizations.

Beyond our Affiliate Program, the IPA has cultivated robust working relationships and memberships within the world's leading psychiatric and geriatric associations. These partnerships allow us to:

🔵Influence Policy: Advocate for older adults at the highest levels of global health.

🔵Bridge Research: Foster cross-disciplinary innovation between organizations.

🔵Standardize Care: Work toward universal excellence in clinical practice.

The Privilege of a Global Network: Our members don't just join an association; they join a worldwide movement. By aligning with these key partners, we ensure that the voice of psychogeriatrics is heard across every continent and specialized field.

Explore our Partner Network🔗https://f.mtr.cool/kareudmhto

02/03/2026

📣We are honored to introduce Dr. Clive Ballard, MD, PhD, as the President-Elect of the International Psychogeriatric Association (IPA). Dr. Ballard brings a wealth of clinical expertise and academic leadership to this role, as we continue to shape the future of geriatric mental health.

🔵Currently a Professor of Age-Related Diseases at Exeter University in the United Kingdom, Dr. Ballard previously served as Pro-Vice Chancellor and Dean of Medicine at the same institution. His visionary work in the field is perhaps best exemplified by his founding of the PROTECT study, a pioneering digital initiative in the UK that has successfully expanded into international collaborations across Canada, Spain, and Norway.

🔵The Privilege of Global Leadership: Under Dr. Ballard’s upcoming presidency, the IPA remains committed to fostering international research and digital innovation to improve the lives of older adults everywhere. Please join us in welcoming Dr. Ballard as he prepares to lead our organization into its next chapter of excellence.

View Full Board Member Profile 🔗https://f.mtr.cool/kbmzfiiajd

02/02/2026

💎 Vidéoconférences gériatriques internationales sur la santé mentale (I-GeMH)

QUAND
Mardi 10 février 2026
De 11 h à 12 h (heure normale de l’Est – HNE)

SUJET
Le dépistage précoce : les bons outils, les bonnes conclusions!

ORATEUR
Robert Laforce, MD PhD

👉 S'INSCRIRE
https://us06web.zoom.us/meeting/register/a25t72uxTrKtcb-A5SteKQ

NOTEZ: Cette activité d’apprentissage est réservée aux clinicien(ne)s, aux étudiant(e)s et aux chercheur(e)s dans le domaine de la santé

Canadian Academy of Geriatric Psychiatry

02/02/2026

The IPA is proud to support the International Geriatric Mental Health Education Network (I-GeMH) in their upcoming Virtual Rounds. This February, we invite our global community of clinicians and researchers to engage in two high-impact sessions focused on neurodevelopmental and diagnostic excellence in older adults.

(English): "Hearts and Minds: Physical and Brain Health in Older Adults with ADHD" Dr. Brandy Callahan (University of Calgary) will explore the clinical profile of ADHD in patients over 50 and its critical relationship with physical health and dementia. 📅 Friday, February 27, 2026 | 8:00 AM ET 🔗 [Register here]: https://f.mtr.cool/uwdbpbpuxn

(French): "Le dépistage précoce : les bons outils, les bonnes conclusions !" Dr. Robert Laforce will lead our francophone series on the essential tools for early screening and accurate diagnostic conclusions. 📅 Mardi 10 février 2026 | 11 h 00 HNE 🔗 [S'inscrire ici]: https://f.mtr.cool/zxnfdslewa

The Privilege of Membership: Staying at the forefront of geriatric psychiatry requires continuous dialogue. These sessions offer CME credits and a community of practice to enhance your clinical expertise.